跳至主要内容
临床试验/NCT03658512
NCT03658512招募中不适用

Tübinger Diabetes Mellitus Database (TUEDID)

University Hospital Tuebingen2 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2018年2月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
2
主要终点
Glycemic control (blood glucose)

研究概览

简要总结

Diabetes mellitus is a widespread disease with increasing prevalence worldwide. Patients with diabetes can develop multiple late complications such as neuropathy, retinopathy, nephropathy and cardiovascular comorbidities. So far, there are no reliable predictive tools or markers to estimate if, when and to what extent a patient with diabetes develops late complications. For the patients quality of life and for health economic reasons an improved risk assessment would be desirable. The prospective TUEDID study will characterize diabetic patients to look out for parameters the predict progression of diabetes and its complications.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >18 years

排除标准

  • no written informed consent

结局指标

主要结局

Glycemic control (blood glucose)

时间窗: At enrolment

Assessed as fasting blood glucose and HbA1C

Glycemic control (HbA1C)

时间窗: At enrolment

Assessed as fasting HbA1C

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验